R&D Challenges of analytical method validation for ATMPs Quality control of medicinal products is a fundamental aspect of assuring the quality, efficacy, and safety of the product.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
Views & Analysis Moving to component management & traceability: progress, bar... Component management is fairly new to the regulatory market, with pharmaceutical firms moving from traditional document management systems to more dynamic component content management syste
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.